Non-secretory multiple myeloma: Diagnosis and management

20Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

Abstract

Multiple myeloma (MM) is one of the most commonly diagnosed blood cancers. One criterion for the diagnosis of MM is serum and/or urine monoclonal protein produced by clonal plasmocytes. However, about 1–2% of MM cases do not have monoclonal protein. If other diagnostic criteria are present, the possibility of a diagnosis of non-secretory MM should be considered. As the different types of non-secretory MM depend on the underlying cause, the current definition is considered insufficient. Currently, both the diagnosis and treatment of non-secretory MM are the same as those of secretory MM. Due to the rarity of non-secretory MM, most findings are from retrospective studies on small groups of patients and case reports. The method of monitoring the effectiveness of MM treatment remains a problem, as it is usually based on the assessment of the percentage of clonal plasma cells in the bone marrow and imaging studies.

Cite

CITATION STYLE

APA

Charliński, G., & Jurczyszyn, A. (2021). Non-secretory multiple myeloma: Diagnosis and management. Advances in Clinical and Experimental Medicine. Wroclaw University of Medicine. https://doi.org/10.17219/ACEM/141455

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free